XML 115 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation
12 Months Ended
Dec. 31, 2013
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Stock-Based Compensation
9. STOCK-BASED COMPENSATION

The P. H. Glatfelter Amended and Restated Long Term Incentive Plan (the “LTIP”) provides for the issuance of Glatfelter common stock to eligible participants in the form of restricted stock units, restricted stock awards, non-qualified stock options, performance shares, incentive stock options and performance units. In May 2013, our shareholders approved an increase of 1,030,000 in the number shares authorized to be issued under the LTIP.

As of December 31, 2013, there were 2,179,443 shares of common stock available for future issuance under the LTIP.

Since the approval of the LTIP, we have issued to eligible participants restricted stock units, performance share awards and stock only stock appreciation rights (“SOSARs”).

 

Restricted Stock Units (“RSUs”) and Performance Share Awards (“PSAs”)    Awards of RSUs and PSAs are made under our LTIP. The vesting of RSUs is generally based on the passage of time, generally on a graded scale over a three, four, and five-year period. Beginning in March of 2011, PSAs were issued annually to members of senior management and each respective grant cliff vests each December 31, assuming the achievement of predetermined, three-year cumulative performance targets. The performance measures include a minimum, target and maximum performance level providing the grantees an opportunity to receive more or less shares than targeted depending on actual financial performance. For both RSUs and PSAs, the grant date fair value of the awards, which is equal to the closing price per common share on the date of the award, is used to determine the amount of expense to be recognized over the applicable service period. Settlement of RSUs and PSAs will be made in shares of our common stock currently held in treasury.

The following table summarizes RSU and PSA activity during the past three years:

 

Units

     2013         2012        2011   

Balance January 1,

     847,679         788,088        579,801   

Granted

     315,196         209,021        251,031   

Forfeited

     (47,831      (52,800     (28,254

Shares delivered

     (113,230      (96,630     (14,490

Balance December 31,

     1,001,814         847,679        788,088   

Dollars in thousands

     2013         2012        2011   

Compensation expense

   $ 2,882       $ 2,576      $ 2,069   

The amount granted in 2013, 2012 and 2011 includes 183,910, 161,083 and 98,187 PSAs, respectively, exclusive of reinvested dividends. The performance period for the 2011 PSAs concluded on December 31, 2013 and, based on actual performance relative to target, approximately 78% of the award were issued to participants in 2014. The weighted average grant date fair value per unit for awards in 2013, 2012 and 2011 was $22.34, $15.49, and $12.47, respectively. As of December 31, 2013, unrecognized compensation expense for outstanding RSUs and PSAs totaled $7.1 million. The weighted average remaining period over which the expense will be recognized is 2.9 years.

 

Stock Only Stock Appreciation Rights    The following table sets forth information related to outstanding SOSARS:

 

     2013      2012      2011  

SOSARS

     Shares       
 
Wtd Avg
Exercise Price
  
  
     Shares       
 
Wtd Avg
Exercise Price
  
  
     Shares       
 
Wtd Avg
Exercise Price
  
  

Outstanding at January 1,

     2,121,454      $ 12.93         2,298,288      $ 12.35         2,061,877      $ 12.28   

Granted

     368,687        18.51         364,114        15.58         345,290        12.56   

Exercised

     (435,562     12.63         (500,074     12.06                  

Canceled / forfeited

     (77,446     16.28         (40,874     14.31         (108,879     11.82   

Outstanding at December 31,

     1,977,133        13.91         2,121,454        12.93         2,298,288        12.35   

Exercisable at December 31,

     1,330,816        12.58         1,469,537        12.30         1,554,852        12.45   

Vested and expected to vest

     1,863,244           2,055,599           2,076,341     
 

SOSAR Grants

              

Weighted average grant date fair value per share

   $ 5.74         $ 4.94         $ 4.09     

Aggregate grant date fair value (in thousands)

   $ 2,103         $ 1,797         $ 1,412     

Black-Scholes assumptions

              

Dividend yield

     2.16        2.31        2.87  

Risk free rate of return

     1.01        1.02        2.55  

Volatility

     39.58        41.48        41.91  

Expected life

     6 yrs           6 yrs           6 yrs     

Compensation expense (in thousands)

   $ 1,591               $ 1,448               $ 1,564           

 

Under terms of the SOSAR, the recipients received the right to receive a payment in the form of shares of common stock equal to the difference, if any, in the fair market value of one share of common stock at the time of exercising the SOSAR and the exercise price. The SOSARs vest ratably over a three year period. As of December 31, 2013, the intrinsic value of SOSARs vested and expected to vest totaled $25.8 million. The remaining weighted average contractual life of outstanding SOSARs was 6.5 years as of December 31, 2013.

Our LTIP also permits the issuance of nonqualified stock options; however, we have not issued any options since 2004. As of December 31, 2013, 10,000 stock options were outstanding with a weighted average exercise price of $11.29 per share. All options expire on the earlier of termination or, in some instances, a defined period subsequent to termination of employment, or ten years from the date of grant. The exercise price represents the quoted market price of Glatfelter common stock on the date of grant, or the average quoted market prices of Glatfelter common stock on the first day before and after the date of grant for which quoted market price information was available if such information was not available on the date of grant. As of December 31, 2013, the intrinsic value of outstanding stock options totaled $0.2 million.